Intuitive Surgical Target of Unusually Large Options Trading (NASDAQ:ISRG)

Intuitive Surgical, Inc. (NASDAQ:ISRG) saw unusually large options trading on Tuesday. Traders purchased 8,950 put options on the stock. This represents an increase of 27% compared to the typical volume of 7,045 put options.

Intuitive Surgical News Summary

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Analysts and bullish articles say Intuitive Surgical has strong procedure momentum and da Vinci 5 adoption, supporting expectations for another earnings beat and a potential second-half rebound. Intuitive Surgical Pre-Q2 Analysis: Buy, Hold or Sell the Stock Now?
• Positive Sentiment: Multiple reports highlight ISRG as an AI-led medical device laggard with improving earnings estimates and strong underlying business momentum, suggesting room for recovery. Buy 3 AI-Led Medical Devices Laggards of 1H Set to Gather Pace in 2H
• Positive Sentiment: Intuitive Surgical is also being cited as one of the large-cap robotics names benefiting from AI, automation, and broader robotics adoption trends. Buy 5 Large-Cap Stocks With Extensive Robotics Applications for 2H 2026
• Neutral Sentiment: Analysts continue to expect a strong Q2 report, with forecasts around $2.50 EPS and about $2.82 billion in revenue ahead of the July 16 release. Intuitive Surgical Likely To Report Higher Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
• Neutral Sentiment: Several firms lowered price targets, including TD Cowen and RBC, but both kept positive ratings, signaling confidence in the long-term story despite near-term caution. Analyst price target revisions
• Negative Sentiment: Downward revisions to price targets and mention of margin pressure may be contributing to the stock’s weakness as investors wait for earnings confirmation. Intuitive Surgical Maintained at Buy as Analyst Sees Favorable Risk‑Reward Despite Cut in Price Target to $520

Wall Street Analyst Weigh In

Several research analysts have weighed in on ISRG shares. Zacks Research lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Monday, March 30th. Deutsche Bank Aktiengesellschaft lowered their price target on Intuitive Surgical from $440.00 to $366.00 and set a “sell” rating for the company in a report on Tuesday, June 2nd. Stifel Nicolaus set a $670.00 price target on Intuitive Surgical in a research report on Tuesday. UBS Group cut their price objective on Intuitive Surgical from $570.00 to $550.00 and set a “neutral” rating on the stock in a report on Tuesday, March 17th. Finally, HSBC decreased their price objective on Intuitive Surgical from $653.00 to $604.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $566.27.

Intuitive Surgical Stock Performance

NASDAQ ISRG traded down $26.47 during trading on Tuesday, hitting $380.65. The stock had a trading volume of 2,047,051 shares, compared to its average volume of 2,165,196. Intuitive Surgical has a 12 month low of $380.00 and a 12 month high of $603.88. The company’s 50-day moving average price is $421.09 and its two-hundred day moving average price is $472.71. The company has a market capitalization of $134.81 billion, a PE ratio of 46.13, a P/E/G ratio of 3.31 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, topping the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The company had revenue of $2.77 billion during the quarter, compared to analysts’ expectations of $2.62 billion. During the same period last year, the business earned $1.81 EPS. The business’s quarterly revenue was up 23.0% on a year-over-year basis. As a group, equities analysts anticipate that Intuitive Surgical will post 8.57 earnings per share for the current fiscal year.

Insider Activity

In other news, SVP Iman Jeddi sold 5,625 shares of the company’s stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $420.55, for a total value of $2,365,593.75. Following the completion of the sale, the senior vice president directly owned 6,463 shares of the company’s stock, valued at $2,718,014.65. This represents a 46.53% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 119 shares of the stock in a transaction on Wednesday, April 29th. The stock was sold at an average price of $463.50, for a total transaction of $55,156.50. Following the completion of the sale, the director owned 120 shares in the company, valued at approximately $55,620. This trade represents a 49.79% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 7,169 shares of company stock valued at $3,059,135 in the last ninety days. 0.60% of the stock is owned by insiders.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Newbridge Financial Services Group Inc. lifted its position in Intuitive Surgical by 300.0% during the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 33 shares in the last quarter. Holos Integrated Wealth LLC bought a new position in shares of Intuitive Surgical in the 4th quarter valued at about $25,000. Olistico Wealth LLC bought a new position in shares of Intuitive Surgical in the 4th quarter valued at about $28,000. Laurel Wealth Advisors LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at about $31,000. Finally, Turning Point Benefit Group Inc. increased its position in shares of Intuitive Surgical by 833.3% in the fourth quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider’s stock valued at $32,000 after acquiring an additional 50 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.